openPR Logo
Press release

Adult Malignant Glioma Therapeutics Market Size, Share, Growth Analysis, Business Insights And Forecast To 2033

04-19-2024 08:32 AM CET | Health & Medicine

Press release from: The Business research company

Adult Malignant Glioma Therapeutics Market

Adult Malignant Glioma Therapeutics Market

The adult malignant glioma therapeutics market size has grown rapidly in recent years. It will grow from $2.03 billion in 2023 to $2.25 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased incidence rates, patient advocacy initiatives, personalized medicine approaches..

The adult malignant glioma therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to immunotherapy advancements, targeted therapies, biomarker discoveries, liquid biopsy applications, expanded access programs.. Major trends in the forecast period include patient-centric drug development, fast-track and breakthrough designation, advances in drug delivery systems, collaborative research initiative, integration of artificial intelligence..

Market Overview -
An adult malignant glioma is a type of brain tumor that originates in the glial cells of the brain or spinal cord. Adult malignant glioma therapeutics refers to the various treatment options available for malignant gliomas in adults, aiming to improve quality of life and prolong survival.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp

Rising Incidence Of Brain Tumors Fuels Growth In The Adult Malignant Glioma Therapeutics Market
The growing cases of brain tumors are expected to drive the adult malignant glioma therapeutics market growth. A brain tumor is an abnormal mass of tissue in which the normal systems that regulate cells appear not to affect the uncontrollable growth and multiplication of the cells. Adult malignant glioma is a type of brain tumor made up of cells that grow abnormally and uncontrollably. Adult malignant glioma treatment treats brain tumors by combining surgery, radiation therapy, and chemotherapy. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of brain and nervous system cancer cases increased to 24,810 in 2023, reflecting a growth of 3.85% from 23,890 in 2020. Therefore, the growing cases of brain tumors are driving the adult malignant glioma therapeutics market.

Competitive Landscape -
Major companies operating in the adult malignant glioma therapeutics market report are Johnson & Johnson Private Limited, Pfizer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Allergan plc, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Abbott Laboratories, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genetech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.

Innovations In Small Molecule Targeted Degraders For Adult Malignant Glioma Therapeutics
Major companies operating in the adult malignant glioma therapeutics market are developing innovative products, such as small molecule targeted degraders, to provide reliable customer service. A small-molecule targeted degrader is a drug that uses small molecules to induce the degradation of specific proteins by targeting the protein of interest (POI) and an E3 ubiquitin ligase. For instance, in February 2023, Beactica Therapeutics AB, a Sweden-based precision oncology company, received orphan drug designation approval from the U.S. Food and Drug Administration (FDA) for BEA-17 to treat glioblastoma (GBM). It is a small-molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST that has been implicated in the pathogenesis of various cancers, including GBM. BEA-17 works by degrading LSD1 and CoREST, which leads to the reactivation of tumor suppressor genes and the inhibition of cancer cell growth.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report

Key Segments -
The adult malignant glioma therapeutics market covered in this report is segmented -
1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types
2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies
3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adult Malignant Glioma Therapeutics Market Size, Share, Growth Analysis, Business Insights And Forecast To 2033 here

News-ID: 3469617 • Views:

More Releases from The Business research company

Image Processing Systems Market to Reach $37.11 Billion by 2028 at 24.7% CAGR within Forecast Period 2024-2033
Image Processing Systems Market to Reach $37.11 Billion by 2028 at 24.7% CAGR wi …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Image Processing Systems Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $37.11 Bn In 2028
Metadata Management Tools Market Set to Reach $24.12 Billion by 2028 at 21.8% CAG
Metadata Management Tools Market Set to Reach $24.12 Billion by 2028 at 21.8% CA …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Metadata Management Tools Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $24.12 Bn In 2028
Flight Data Monitoring Market to Reach $8.65 Billion by 2028, Growing at 9.5% CAGR
Flight Data Monitoring Market to Reach $8.65 Billion by 2028, Growing at 9.5% CA …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Flight Data Monitoring Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $8.65 Bn In 2028
Engineering Software Market Expected to See Strong Growth, Reaching $102.55 Billion by 2028
Engineering Software Market Expected to See Strong Growth, Reaching $102.55 Bill …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Engineering Software Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $102.55 Bn In 2028 At

All 5 Releases


More Releases for Adult

Adult Gastroenterology Associates Consolidates Offices
Adult Gastroenterology Associates (AGA), founded in 1987 and still the only independent gastroenterology practice in Tulsa, is combining all of their practices under one roof in the Richmond Plaza Building. The new location at 4200 E. Skelly Drive will be in the same building as the Tulsa Endoscopy Center, a partner company of AGA. The team members at AGA pride themselves on being completely centered on their patients and what
Adult Toys Market
The global Adult Toys market is valued at 16200 million US$ in 2018 and will reach 34100 million US$ by the end of 2025, growing at a CAGR of 9.8% during 2019-2025. The Market Insights Reports has published the obtainability of a new statistical data to its repository titled as, Adult Toys Market. The report provides useful insights into a wide range of business aspects such as pillars, features, sales strategies,
Global Adult Vaccines Market Research Report
This report studies the global Adult Vaccines market status and forecast, categorizes the global Adult Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer BioCSL (Seqirus) Protein Sciences Geographically, this report studies the top producers
Global Protein Smoothie Market For Adult Male, Adult Female, Youth
Latest industry research report on: Global Protein Smoothie Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. In this report, the global Protein Smoothie market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. In addition, drivers, restraints and opportunities, competitive landscape have also been
United States Protein Cookie Market For Adult Male, Adult Female, Youth
Latest industry research report on: United States Protein Cookie Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. In this report, the United States Protein Cookie market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. In addition, drivers, restraints and opportunities, competitive landscape have
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Wo …
Albany, New York, July 18, 2017 : Recent research and the current scenario as well as future market potential of " Worldwide Adult Vaccines Industry : Key Trends, Challenges and Standardization 2017 " globally. Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age